HomeNewsNeuroscience

  • FDA approves Medtronic’s Brain Stimulation Therapy for Refractory Epilepsy

    • May 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alkermes to Present Clinical Data related to Schizophrenia and Depression at American Psychiatric Association Annual Meeting

    • May 2, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Epilepsy has no impact on pregnancy for women, study finds

    • May 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • EMD Serono using technology to bring MS experience to life

    • May 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Music makes Alzheimer’s symptoms more manageable, claims recent study

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New long term data for Copaxone presented by Teva at AAN

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ACADIA Pharmaceuticals reaffirms Nuplazid’s Benefit/Risk Profile

    • April 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Allergan’s Ubrogepant registers second Positive Ph 3 Trial results in Migraine

    • April 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Schizophrenia drug ALKS 3831 completes Patient enrollment in a pivotal study

    • April 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New data demonstrates Eptinezumab Increased Migraine-Free Intervals and improved Quality-of-Life Outcomes in Episodic Migraine patients

    • April 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more